Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Microfluidic ELISA

By Drug Discovery Trends Editor | September 10, 2012

Tecan and Siloam Biosciences Inc. announce their intent to co-market an automated low-volume, high-sensitivity microfluidic ELISA. The system is based on Tecan’s Freedom EVO liquid handling technology and the Siloam Biosciences’ OptiMax microplate. It offers rapid, sensitive and specific chemifluorescence-based ELISA procedures using exceedingly small sample volumes. The speed, sensitivity and small sample requirements are achieved as a result of the unique microfluidic design of the Optimiser technology. All reactions, including analyte capture and detection, occur within an ~5 μl microfluidic reaction chamber. The unique microchannel geometry and small reaction volume favor rapid reaction kinetics. A typical assay requires only a 5 μl sample and each reaction step is completed within 10 to 20 minutes. With wash times, substrate incubations and read times accounted for, a typical Optimiser technology-based ELISA can be completed within two hours. Exploiting these rapid reaction kinetics on a microscale, coupled with microplate automation on the Freedom EVO workstation, allows for extremely high sensitivity or very fast assays.

Automating the process with the Freedom EVO workstation further enhances Optimiser ELISA efficiency and increases throughput. The Freedom EVO automatically loads analytes and reagents into the wells of the microfluidic microplate, and allows the robotic manipulation of multiple OptiMax microplates. Automation with the Freedom EVO offers distinct performance benefits, including improved pipetting precision at very low volumes, precise control of dispensing times allowing for short incubation cycles, precise operation of the repeat load process dramatically improving sensitivity, and increased productivity allowing the user to attend to other tasks while the instrument is in operation. A fully integrated read-out of the chemifluorescent signal is provided by Tecan’s Infinite M200 microplate reader.

Kevin Moore, Head of Applications and Solutions at Tecan, said: “We are delighted to be working with Siloam Biosciences and are looking forward to bringing our customers a new option for running automated ELISAs using the very exciting new technology of microplate-based microfluidics.”

Aniruddha Puntambekar, Chief Operating Officer at Siloam Biosciences Inc., added: “Tecan’s automation systems enhance the performance of OptiMax automation plates and we are pleased to be able to offer improvements to ELISA users based on Tecan’s automation expertise. Together, our technologies provide significant advances to immunoassay testing that will benefit customers of both companies.”

Tecan


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE